drugset / Trial / NCT03524963
Comparative Pharmacokinetic Study Between Two Extended-Release Cilostazol Formulations in Korea
RandomizedCrossoverOpen-labelTreatment
Summary
This is a randomized, open-label, multiple-dose, two-sequence, two-period crossover study to to compare the safety/tolerability and pharmacokinetics between Pletaal SR Cap. and Cilostan CR Tab. in healthy volunteers
Timeline
- Start
- 2017-08-07
- Primary completion
- 2018-05-30
- Completion
- 2018-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cilostazol | Small molecule | 200 mg | — |